Eagle Wealth Strategies LLC Acquires New Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Eagle Wealth Strategies LLC acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 519 shares of the company’s stock, valued at approximately $211,000.

Other hedge funds have also bought and sold shares of the company. CreativeOne Wealth LLC bought a new stake in HCA Healthcare during the first quarter valued at approximately $231,000. New Mexico Educational Retirement Board lifted its position in HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares during the last quarter. Kingswood Wealth Advisors LLC bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $566,000. Teachers Retirement System of The State of Kentucky lifted its holdings in shares of HCA Healthcare by 15.6% in the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock worth $53,922,000 after acquiring an additional 26,919 shares during the last quarter. Finally, Brave Warrior Advisors LLC lifted its holdings in shares of HCA Healthcare by 182.1% in the 4th quarter. Brave Warrior Advisors LLC now owns 3,873 shares of the company’s stock worth $1,048,000 after acquiring an additional 2,500 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the sale, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 over the last three months. 1.60% of the stock is owned by company insiders.

Analysts Set New Price Targets

HCA has been the subject of a number of recent research reports. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Barclays upped their price target on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. Finally, Leerink Partners boosted their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have issued a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Stock Performance

Shares of HCA traded down $0.34 on Wednesday, reaching $378.24. The company’s stock had a trading volume of 136,907 shares, compared to its average volume of 1,132,452. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $409.42. The stock has a market capitalization of $99.07 billion, a P/E ratio of 18.87, a PEG ratio of 1.52 and a beta of 1.67. The stock’s 50 day simple moving average is $385.44 and its two-hundred day simple moving average is $346.48.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter in the previous year, the business posted $4.29 earnings per share. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. Research analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.70%. The ex-dividend date of this dividend was Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.